Recent calculations by Viridian Capital Advisors have shed light on the significant impact that eliminating Section 280e could have on the cannabis industry. This impact could potentially outweigh the effects of the SAFE Act and a TSX uplisting. Section 280e, a provision in the Internal Revenue Code, restricts businesses from deducting ordinary expenses associated with the “trafficking” of Schedule I or II substances, as defined by the Controlled Substances Act.
Germany has received nearly 900 applications for cannabis cultivation associations, but only just over half…
A Senate stopgap funding bill would delay the federal prohibition on most hemp-derived THC products…
He smokes in boardrooms, but he’s still on that underground frequency. This content originally appeared…
Fox News opinion ran a piece recently from Scott Chipman, vice president of Americans Against…
For our 50th anniversary, we handed the plant to the artists making its most striking…
Corporate valuation increased in 21 of the 38 states studied following medical marijuana legalization. Gross…